FDA Inspection 1191835 — Scinopharm Taiwan, Ltd.
The FDA completed an inspection of Scinopharm Taiwan, Ltd. on Oct 25, 2022 in Tainan City. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 25, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Tainan City (Taiwan)